Two treatments that slow the development of diabetes also may protect people from heart disease, according to a recent study accepted for publication in The Endocrine Society’s Journal of Clinical Endocrinology & Metabolism (JCEM).
Evidence from people with heart disease strongly supports the existence of the molecular link first discovered in laboratory mice between the body’s natural circadian rhythms and cardiac arrest or sudden cardiac death — the No. 1 cause of death in heart attacks, a scientist said here today at the 246th National Meeting & Exposition of the American Chemical Society, the world’s largest scientific society.
The small size and abnormal anatomy of children born with heart defects often force doctors to place lifesaving defibrillators entirely outside the heart, rather than partly inside — a less-than-ideal solution to dangerous heart rhythms that involves a degree of guesstimating and can compromise therapy.
Older heart patients present unique challenges for determining the optimal dosages of medications, so a new study from researchers at Duke Medicine offers some rare clarity about the use of drugs that are used to treat patients with heart attacks.
Researchers from Case Western Reserve University School of Medicine and the Dana-Farber Cancer Institute have discovered a new molecular pathway responsible for causing heart failure and showed that a first-in-class prototype drug, JQ1, blocks this pathway to protect the heart from damage.
Vanderbilt Heart and Vascular Institute is participating in the VELOCITY study, a randomized controlled clinical study to assess the safety and feasibility of a rapid cooling system for heart attack patients that could minimize damage to the heart.
American Association of Physicians of Indian Origin (AAPI) has launched educational ”Networks” of renowned thought leaders in the areas of Cardiology, Diabetes, and Stroke to foster high quality medical education of physicians of Asian Indian origin in the US.
An analysis of data from three studies that involved a total of more than 240,000 participants found that a self-reported history of kidney stones was associated with a statistically significant increased risk of coronary heart disease among women but no significant association was evident for men, according to a study in the July 24/31 issue of JAMA.
A Johns Hopkins study finds that healthy people who carry a genetic mutation for arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) are at much higher risk of developing the symptoms of the life-threatening heart disease if they participate in endurance sports and frequent exercise. The study also suggests that those carriers who significantly cut back on their exercise regimen may reduce their risk or delay the onset of symptoms.
St. Jude Children’s Research Hospital scientists have discovered that a protein used by cancer cells to evade death also plays a vital role in heart health.
Drugs that help millions of people cope with acid reflux may also cause cardiovascular disease. It is the first time researchers have shown how proton pump inhibitors, or PPIs, might cause cardiovascular problems.
Programs to address multiple health behaviors, such as diet and exercise, significantly lowered the risk of a fatal heart attack, stroke or other cardiovascular event in people with coronary heart disease, finds a new study in the American Journal of Preventive Medicine.
Researchers led by M. Mahmood Hussain, PhD, found that a regulatory RNA molecule interferes with the production of lipoproteins and, in a mouse model, reduces hyperlipidemia and atherosclerosis.
A new heart valve that can be implanted inside an existing valve will help adults with congenital heart disease avoid open heart surgeries.
Too much sugar can set people down a pathway to heart failure, according to a study led by researchers at The University of Texas Health Science Center at Houston (UTHealth).
Mayo Clinic has announced the first U.S. stem cell clinical trial for pediatric congenital heart disease. The trial aims to determine how stem cells from autologous umbilical cord blood can help children with hypoplastic left heart syndrome (HLHS), a rare defect in which the left side of the heart is critically underdeveloped.
Mice suffering from age-related heart disease saw a significant improvement in cardiac function after treatment with the FDA-approved drug rapamycin for just three months. Research at the Buck Institute shows how rapamycin impacts mammalian tissues, providing functional insights and possible benefits for a drug that can extend lifespan in mice as much as 14 percent. Researchers at the Mayo clinic are now recruiting seniors with cardiac artery disease for a clinical trial involving the drug.
Pulse oximetry test, already used at UCLA, will be mandatory statewide July 1.
Two biomarkers being investigated as predictors of heart and vascular disease appear to indicate risk for "silent" strokes and other causes of mild brain damage that present no symptoms, report researchers in an upcoming issue of Stroke.
The more heart attack-induced PTSD symptoms a patient has, the worse their sleep likely was in the month following their heart attack. New findings from a research team at Columbia University Medical Center’s Center for Behavioral Cardiovascular Health, published in the Annals of Behavioral Medicine.
UCLA researchers examining outcomes for advanced heart-failure patients over the past two decades have found that, coinciding with the increased availability and use of new therapies, overall mortality has decreased and sudden cardiac death, caused by the rapid onset of severe abnormal heart rhythms, has declined. However, the team found that even today, with these significant improvements, one-third of patients don’t survive more than three years after being diagnosed with advanced disease.
Patients with underlying heart failure are more likely to experience adverse outcomes from mild hypothyroidism, according to a recent study accepted for publication in The Endocrine Society’s Journal of Clinical Endocrinology & Metabolism (JCEM).
Why is fish oil good for the heart? A new study suggests that this omega 3 fatty acid-rich nutrient could blunt some cardiovascular effects of mental stress.
Scientists at the Texas Biomedical Research Institute in San Antonio have identified four genes in baboons that influence levels of “bad” cholesterol. This discovery could lead to the development of new drugs to reduce the risk of heart disease.
Although genetic factors contribute to congenital heart disease, many children born with heart defects have healthy parents and siblings, suggesting that new mutations that arise spontaneously—known as de novo mutations—might contribute to the disease. New research shows that about 10 percent of these defects are caused by genetic mutations that are absent in the parents of affected children.
A commentary and review provides clinicians with the optimal utilization of aspirin to treat and prevent heart attacks, and advice on aspirin in the prevention of colorectal and other cancers.
Type 1 (insulin-dependent) diabetes appears to increase the risk of heart disease, the leading cause of death among people with high blood sugar, partly by stimulating the production of calprotectin, a protein that sparks an inflammatory process that fuels the buildup of artery-clogging plaque.
Your genetic makeup can help determine how well your body will respond to weight loss efforts aimed at controlling high blood pressure, a new study confirms. The multi-institutional study, led by researchers at The Cardiovascular Institute, part of the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, may help clarify how hypertension develops and progresses in certain individuals and also identify people for whom weight loss programs are most likely to help reduce blood pressure.
Findings pinpoint 14 genetic targets in humans that may provide insight for the treatment of cardiovascular disease.
Mayo Clinic physicians in Arizona have shown that tablet computers can be used to analyze electroencephalogram or EEG results outside of the clinic or hospital. Their study findings were recently presented at the American Academy of Neurology conference in San Diego.
In what promises to be an eye-opener for many doctors and patients who routinely depend on cholesterol testing, a study led by researchers at the Johns Hopkins University School of Medicine found that the standard formula used for decades to calculate low-density lipoprotein (LDL) cholesterol levels is often inaccurate. Of most concern, the researchers say, is their finding that the widely used formula underestimates LDL where accuracy matters most — in the range considered desirable for high-risk patients. Results of the study are published in an online article, ahead of print, in the Journal of the American College of Cardiology.
Depressive symptoms after heart disease are associated with a markedly increased risk of death or another heart attack. However, less has been known about whether treating heart attack survivors for depressive symptoms could relieve these symptoms, be cost-effective, and ultimately, reduce medical risk? Columbia University Medical Center’s Karina W. Davidson, PhD and her research team now report a patient-centered approach that answers these questions in the affirmative.
Long-term cognitive and functional impairments that follow pneumonia hospitalization are comparable to the negative health effects of heart disease.
A new study in the March 2013 Women’s Health Issues evaluates the Heart Truth educational campaign on provider knowledge of heart disease as it affects women. The team of researchers studied the delivery of The Heart Truth® Professional Education Campaign across three states to diverse audiences of healthcare providers. All of the healthcare providers showed improved knowledge on women and heart disease after participating in the lectures.
After reviewing previous research on gum disease and obesity, researchers found inflammation is the association between both health problems, which they describe in the Journal of General Dentistry article, “Obesity and periodontitis: a link.”
Data show need for OB/GYNs to play expanded role in educating, preventing heart disease for women in reproductive years.
Jared M. O'Leary, M.D., of Brigham and Women's Hospital, Boston, and colleagues analyzed U.S. hospitalizations from 1998 through 2010 for children and adults with congenital heart disease. “There are more than 787,000 adults with congenital heart disease in the United States. Adults with congenital heart disease remain at risk for frequent hospitalizations,” the authors write in a Research Letter published online by JAMA to coincide with its presentation at the American College of Cardiology's annual Scientific Sessions.
Ulhas Naik, director of the Delaware Cardiovascular Research Center based at the University of Delaware, is working to synthesize a new compound to block a stress enzyme critical to clot formation.
Chinese women are less likely to develop cardiovascular disease if they have their first menstrual cycle or enter menopause later than their peers, according to a recent study accepted for publication in The Endocrine Society’s Journal of Clinical Endocrinology & Metabolism (JCEM).
Findings show that measurements of carbamylated albumin may help doctors in monitoring dialysis patients; further suggests that amino acid supplementation could help offset carbamylation process
The poor growth seen in children born with complex heart defects may result from factors beyond deficient nutrition. A new study by pediatric researchers suggests that abnormalities in overall growth regulation play a role.
Hopkins Nursing student uses a support tool with Framingham Risk Score to identify endangered patients the widely accepted FRS missed.
St. Jude Children’s Research Hospital investigators found evidence that chest irradiation may leave some adult survivors of childhood cancer in danger of developing pulmonary hypertension in middle age.
In recognition of February as American Heart Month, the American College of Occupational and Environmental Medicine is providing tools and resources to help employers identify and respond to the impact of hypertension – a leading risk factor for heart disease – on worker health and productivity.
If you exercise, eat right and don’t smoke, a history of heart disease in your family can still put you at risk – even if you are a female.
February is American Heart Month, a perfect time to remind people that small steps can reduce their risk of heart disease, the No. 1 killer of men and women. Mayo Clinic cardiologists offer several simple tips to reduce the risk.
On the first Friday of each February, The American Heart Association (AHA) urges Americans to wear red to raise awareness about women’s heart health. Each year, women from all walks of life heed the call, donning AHA’s Go Red for Women pin, red outfits and accessories. Yet after Go Red Day, many women once again forget to take action for heart health. This dangerous lack of awareness is why the Healthy Monday initiative is urging Americans to go beyond Go Red Day and sport something red every Monday.
A new study could provide the link that scientists have been looking for to confirm that reactivation of a latent herpes virus is a cause of some heart problems.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right